The results are consistent with the established pathophysiology of FXIII deficiency, which is characterized by heterozygous carriers exhibiting intermediate activity levels as a result of decreased FXIII-A or FXIII-B subunit production or function. Here, F13B is linked to hyperinsulinemic hypoglycemia, familial, 4.